Minimally invasive technologies for surgical treatment of kidney cancer

The OBJECTIVE was to analyze the developmental trends, possibilities and outcomes of applying minimally invasive technologies in surgical treatment for kidney cancer.METHODS AnD MATERIALS. The study included 368 surgeries for kidney tumors which were performed from 2012 to 2019. Partial nephrectomy...

Full description

Saved in:
Bibliographic Details
Main Authors: S. A. Rakul, P. N. Romashchenko, K. V. Pozdnyakov, N. A. Maistrenko, R. A. Eloev
Format: Article
Language:Russian
Published: Pavlov First Saint Petersburg State Medical University 2021-04-01
Series:Вестник хирургии имени И.И. Грекова
Subjects:
Online Access:https://www.vestnik-grekova.ru/jour/article/view/1634
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849771877977817088
author S. A. Rakul
P. N. Romashchenko
K. V. Pozdnyakov
N. A. Maistrenko
R. A. Eloev
author_facet S. A. Rakul
P. N. Romashchenko
K. V. Pozdnyakov
N. A. Maistrenko
R. A. Eloev
author_sort S. A. Rakul
collection DOAJ
description The OBJECTIVE was to analyze the developmental trends, possibilities and outcomes of applying minimally invasive technologies in surgical treatment for kidney cancer.METHODS AnD MATERIALS. The study included 368 surgeries for kidney tumors which were performed from 2012 to 2019. Partial nephrectomy (Pn) was performed in 228 (60.6 %) cases, radical nephrectomy (Rn) – in 148 (39.4 %) cases. Tumors of the stage cT1a detected in 148 (39.4 %), сТ1b – 145 (38.6 %), сT2a – 58 (15.4 %), сТ2b-cTxn1M1 – 25 (6.7 %) patients. Operations were performed using open (3.7 %), laparoscopic (50.3 %), robotic (46.0 %) approaches with assessment of surgical and oncological outcomes of treatment.RESULTS. The incidence rate of Pn in patients with kidney cancer at the stages cT1a, cT1b and cT2a was 89.9, 57.2 and 20.7 %. Rn was performed in all cases of tumor stage сТ2b-cTxn1M1. The frequency of Pn at the stages cT1a, cT1b and cT2a in 2019 exceeded 80 %. Minimally invasive technologies (MIT) for Pn was used in 98.3 %, for Rn – in 92.2 % of cases. The incidence rate of postoperative complications after Pn and Rn at stages сТ1а, сT1b, сТ2а was 14.3and 6.7, 16.9 and 3.2, 16.7 and 2.2 %, respectively. Complications after Rn at tumors of the stage cT2bcTxn1M1 occurred in 20.0 % of patients. Positive surgical margin (PSM) occurred after Pn for tumors of the stage cT1a in 0.7 % of cases; for cT1b – in 2.4 %; for cT2a and after Rn – was not determined.CONCLUSION. Our study demonstrates a steady tendency towards an increase in the number of MIT for kidney tumors, including when performing organ-preserving surgeries. Robot-assisted surgery allows to expand the indications to use a minimally MIT even in the most difficult clinical cases. The frequency of complications after RP compared with Rn is higher because the complexity of the operation increases, and these complications did not affect the outcome of treatment, taking into account the functional advantages provided for patients. The development and widespread introduction of minimally MIT into clinical practice is an evident and inevitable way to develop surgical treatment of kidney cancer.
format Article
id doaj-art-34fd2a98bcec459e9fe9bc36d6a72bb1
institution DOAJ
issn 0042-4625
language Russian
publishDate 2021-04-01
publisher Pavlov First Saint Petersburg State Medical University
record_format Article
series Вестник хирургии имени И.И. Грекова
spelling doaj-art-34fd2a98bcec459e9fe9bc36d6a72bb12025-08-20T03:02:29ZrusPavlov First Saint Petersburg State Medical UniversityВестник хирургии имени И.И. Грекова0042-46252021-04-011796344310.24884/0042-4625-2020-179-6-34-431201Minimally invasive technologies for surgical treatment of kidney cancerS. A. Rakul0P. N. Romashchenko1K. V. Pozdnyakov2N. A. Maistrenko3R. A. Eloev4City Hospital № 40 of Kurortny District; Military Medical AcademyMilitary Medical AcademyCity Hospital № 40 of Kurortny DistrictMilitary Medical AcademyCity Hospital № 40 of Kurortny DistrictThe OBJECTIVE was to analyze the developmental trends, possibilities and outcomes of applying minimally invasive technologies in surgical treatment for kidney cancer.METHODS AnD MATERIALS. The study included 368 surgeries for kidney tumors which were performed from 2012 to 2019. Partial nephrectomy (Pn) was performed in 228 (60.6 %) cases, radical nephrectomy (Rn) – in 148 (39.4 %) cases. Tumors of the stage cT1a detected in 148 (39.4 %), сТ1b – 145 (38.6 %), сT2a – 58 (15.4 %), сТ2b-cTxn1M1 – 25 (6.7 %) patients. Operations were performed using open (3.7 %), laparoscopic (50.3 %), robotic (46.0 %) approaches with assessment of surgical and oncological outcomes of treatment.RESULTS. The incidence rate of Pn in patients with kidney cancer at the stages cT1a, cT1b and cT2a was 89.9, 57.2 and 20.7 %. Rn was performed in all cases of tumor stage сТ2b-cTxn1M1. The frequency of Pn at the stages cT1a, cT1b and cT2a in 2019 exceeded 80 %. Minimally invasive technologies (MIT) for Pn was used in 98.3 %, for Rn – in 92.2 % of cases. The incidence rate of postoperative complications after Pn and Rn at stages сТ1а, сT1b, сТ2а was 14.3and 6.7, 16.9 and 3.2, 16.7 and 2.2 %, respectively. Complications after Rn at tumors of the stage cT2bcTxn1M1 occurred in 20.0 % of patients. Positive surgical margin (PSM) occurred after Pn for tumors of the stage cT1a in 0.7 % of cases; for cT1b – in 2.4 %; for cT2a and after Rn – was not determined.CONCLUSION. Our study demonstrates a steady tendency towards an increase in the number of MIT for kidney tumors, including when performing organ-preserving surgeries. Robot-assisted surgery allows to expand the indications to use a minimally MIT even in the most difficult clinical cases. The frequency of complications after RP compared with Rn is higher because the complexity of the operation increases, and these complications did not affect the outcome of treatment, taking into account the functional advantages provided for patients. The development and widespread introduction of minimally MIT into clinical practice is an evident and inevitable way to develop surgical treatment of kidney cancer.https://www.vestnik-grekova.ru/jour/article/view/1634kidney cancerpartial nephrectomyrobotic¬assisted partial nephrectomyminimally invasive surgerycomplications of partial nephrectomy
spellingShingle S. A. Rakul
P. N. Romashchenko
K. V. Pozdnyakov
N. A. Maistrenko
R. A. Eloev
Minimally invasive technologies for surgical treatment of kidney cancer
Вестник хирургии имени И.И. Грекова
kidney cancer
partial nephrectomy
robotic¬assisted partial nephrectomy
minimally invasive surgery
complications of partial nephrectomy
title Minimally invasive technologies for surgical treatment of kidney cancer
title_full Minimally invasive technologies for surgical treatment of kidney cancer
title_fullStr Minimally invasive technologies for surgical treatment of kidney cancer
title_full_unstemmed Minimally invasive technologies for surgical treatment of kidney cancer
title_short Minimally invasive technologies for surgical treatment of kidney cancer
title_sort minimally invasive technologies for surgical treatment of kidney cancer
topic kidney cancer
partial nephrectomy
robotic¬assisted partial nephrectomy
minimally invasive surgery
complications of partial nephrectomy
url https://www.vestnik-grekova.ru/jour/article/view/1634
work_keys_str_mv AT sarakul minimallyinvasivetechnologiesforsurgicaltreatmentofkidneycancer
AT pnromashchenko minimallyinvasivetechnologiesforsurgicaltreatmentofkidneycancer
AT kvpozdnyakov minimallyinvasivetechnologiesforsurgicaltreatmentofkidneycancer
AT namaistrenko minimallyinvasivetechnologiesforsurgicaltreatmentofkidneycancer
AT raeloev minimallyinvasivetechnologiesforsurgicaltreatmentofkidneycancer